Mesothelin has been shown to be overexpressed in many human cancers, including mesothelioma, ovarian cancer, pancreatic cancer, lung cancer, gastric cancer, and biliary cancer [12, 17–22]. This evidence concerns the gene MSLN and gastric cancer.